Clinical Trial Update: Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase

View source ↗

Summary

A completed clinical trial evaluating piperacillin/tazobactam for bacteremia caused by organisms producing chromosomally encoded AmpC beta-lactamase.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia

Drugs mentioned

• Piperacillin-tazobactam (Zosyn) (piperacillin/tazobactam)

Snippet

Sponsor: University of Pittsburgh | Conditions: Bacteremia, AmpC Beta-lactamase | Status: COMPLETED